New memory for HIV patients

March 26, 2012

The hallmark loss of helper CD4+ T cells during human immunodeficiency virus (HIV) infection may be a red herring for therapeutics, according to a study published on March 26th in the Journal of Experimental Medicine.

HIV preferentially infects CD4+ T cells, required to generate protective antibodies. In many people, this leads to a progressive drop in CD4+ numbers—and the more the numbers fall, the faster AIDS develops. HIV-induced cell loss includes both 'naive' CD4+ T cells (those that have never encountered a pathogen) and 'memory' CD4+ T cells (fast-acting cells that 'remember' a previous encounter with a pathogen). Normally, newly generated naive CD4+ T cells can help to replace their lost memory brethren. Thus replacing these naive CD4+ T cells in AIDS patients has become a focus for some anti-viral therapy.

However, by wiping out all naive T cells in monkeys, Louis Picker and colleagues at Oregon Health & Science University found that these cells do little to help combat the virus and delay AIDS, although the overall immune response to virus was dampened in their absence. The loss of naive CD4+ T cells also had no effect on the maintenance of memory CD4+ T cells, whose loss proceeded similarly with or without naive cell replacements.

The authors argue that augmenting memory T cells rather than naive ones may provide more benefit. Whether these findings will correspond to human HIV disease remains to be seen.

Explore further: Study finds HIV-specific CD4 cells that control viral levels

More information: Okoye, A., et al. 2012. J. Exp. Med. doi:10.1084/jem.20112071

Related Stories

Study finds HIV-specific CD4 cells that control viral levels

February 29, 2012

A subpopulation of the immune cells targeted by HIV may play an important role in controlling viral loads after initial infection, potentially helping to determine how quickly infection will progress. In the February 29 issue ...

Recommended for you

HIV vaccine design should adapt as HIV virus mutates

May 16, 2016

Human immunodeficiency virus is known to be a highly variable virus that adapts to a person's immune response during the lifetime infection, and a new study published in Nature Medicine shows that viral adaptation in HIV ...

Study discovers new HIV vaccine target

May 12, 2016

A team led by scientists at the National Institutes of Health (NIH) has reported a research trifecta. They discovered a new vulnerable site on HIV for a vaccine to target, a broadly neutralizing antibody that binds to that ...

Researchers find alternative pathways to HIV antibodies

May 4, 2016

The immune system appears to hamper an investigational vaccine from inducing antibodies that protect against HIV infection, but there may be ways to overcome this impediment, according to research led by the Duke Human Vaccine ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.